REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/24/2025
Back to search
Official data from USPTO
INNOVENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
64
Latest update
03/25/2025
Trademark type
Combined
Nice classes
5
Filing date
04/16/2018
Registration date
03/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2020
Last transaction
03/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CN
Examiner
ROACH, APRIL
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The trademark consists of the English letters of "I", "N", "N", "O", "V", "E", "N" and "T", in which the English letter "O" is designed by two symmetrical arcs. The mark has no particular meaning when taken as a whole.
Holders and representatives
Holders
Innovent Biologics (Suzhou) Co., Ltd.
Representatives
Anessa Owen Kramer Honigman LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposesantibody preparationsprotein preparationsblood preparationshormonesenzymestoxoidsorganic compounds and hemopoietic growth factorsmedicines for the treatment of tumorophthalmologic diseasesimmunological mediated diseasesmetabolic diseasesblood diseasesdiabetesendocrine diseasereproductive system diseasecentral and peripheral nervous system diseasehereditary diseasesantiviral drugs; Pharmaceutical preparationsantibody preparationsprotein preparationblood preparationshormonesenzymestoxoidsorganic compounds and hemopoietic growth factorsmedicines for the treatment of tumorophthalmologic diseasesimmunological mediated diseasesmetabolic diseasesblood diseasesdiabetesendocrine diseasereproductive system diseasecentral and peripheral nervous system diseasehereditary diseasesantiviral drugs; Vaccines; drugs for medical purposesantibody preparationsprotein preparationblood preparationshormonesenzymestoxoidsorganic compounds and hemopoietic growth factorsmedicines for the treatment of tumorophthalmologic diseasesimmunological mediated diseasesmetabolic diseasesblood diseasesdiabetesendocrine diseasereproductive system diseasecentral and peripheral nervous system diseasehereditary diseasesantiviral drugs; Biological preparations for medical purposesantibody preparationsprotein preparationblood preparationshormonesenzymestoxoidsorganic compounds and hemopoietic growth factorsmedicines for the treatment of tumorophthalmologic diseasesimmunological mediated diseasesmetabolic diseasesblood diseasesdiabetesendocrine diseasereproductive system diseasecentral and peripheral nervous system diseasehereditary diseasesantiviral drugs; Diagnostic preparations for medical purposes; Biological tissue cultures for medical purposes; Chemical reagents for medical purposes; all of the aforesaid excluding goods in gaseous formgoods related to nitric oxideveterinary productspreparationsreagentsmedicine for animal health
Publications
History of USPTO decisions and trademark events.
64 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/31/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/10/2020
FIMP
FINAL DISPOSITION PROCESSED
07/10/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/25/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/24/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2020
PUBO
PUBLISHED FOR OPPOSITION
01/07/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/03/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/18/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/18/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/13/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/04/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/04/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/04/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/04/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/27/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/18/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/18/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/18/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/29/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/29/2019
GAUN
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
10/28/2019
GAUD
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
10/28/2019
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
10/28/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/25/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/25/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/25/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/13/2019
GNFR
FINAL REFUSAL E-MAILED
08/13/2019
CNFR
FINAL REFUSAL WRITTEN
08/13/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/16/2019
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
01/18/2019
DMCC
DATA MODIFICATION COMPLETED
12/12/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/11/2018
GNSL
LETTER OF SUSPENSION E-MAILED
12/11/2018
CNSL
SUSPENSION LETTER WRITTEN
12/11/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
12/07/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/26/2018
DMCC
DATA MODIFICATION COMPLETED
11/26/2018
ALIE
ASSIGNED TO LIE
11/21/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/19/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/19/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/19/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/19/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/19/2018
RFNT
REFUSAL PROCESSED BY IB
09/07/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/20/2018
RFRR
REFUSAL PROCESSED BY MPU
08/20/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/04/2018
CNRT
NON-FINAL ACTION WRITTEN
08/03/2018
DOCK
ASSIGNED TO EXAMINER
08/03/2018
MAFR
APPLICATION FILING RECEIPT MAILED
07/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
06/25/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/21/2018
Continuous trademark protection
Get notified about every new filing that threatens INNOVENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.